Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase I/IIa clinical trial (Q36428437)

14 August 2017

Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase I/IIa clinical trial (English)

1 reference

14 August 2017

phase I clinical trial

0 references

author name string

Hiroshi Takahashi

1

1 reference

14 August 2017

Masashi Yamazaki

2

1 reference

14 August 2017

Akihiko Okawa

3

1 reference

14 August 2017

Tsuyoshi Sakuma

4

1 reference

14 August 2017

Kei Kato

5

1 reference

14 August 2017

Mitsuhiro Hashimoto

6

1 reference

14 August 2017

Koichi Hayashi

7

1 reference

14 August 2017

Takeo Furuya

8

1 reference

14 August 2017

Takayuki Fujiyoshi

9

1 reference

14 August 2017

Junko Kawabe

10

1 reference

14 August 2017

Tomonori Yamauchi

11

1 reference

14 August 2017

Chikato Mannoji

12

1 reference

14 August 2017

Tomohiro Miyashita

13

1 reference

14 August 2017

Ryo Kadota

14

1 reference

14 August 2017

Masayuki Hashimoto

15

1 reference

14 August 2017

Yasuo Ito

16

1 reference

14 August 2017

Kazuhisa Takahashi

17

1 reference

14 August 2017

Masao Koda

18

1 reference

14 August 2017

6 March 2012

1 reference

14 August 2017

European Spine Journal

1 reference

14 August 2017

21

1 reference

14 August 2017

12

1 reference

14 August 2017

2580-2587

1 reference

Neuroprotective therapy using granulocyte colony-stimulating factor for patients with worsening symptoms of compression myelopathy, Part 1: a phase I and IIa clinical trial

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508205

CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508205

Preliminary investigation of effect of granulocyte colony stimulating factor on amyotrophic lateral sclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508205

Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508205

Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508205

Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508205

A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508205

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508205

G-CSF suppresses edema formation and reduces interleukin-1beta expression after cerebral ischemia in mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508205

G-CSF: a key regulator of neutrophil production, but that's not all!

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508205

Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508205

Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508205

Peripheral blood stem cell mobilization and apheresis: analysis of adverse events in 94 normal donors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508205

Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508205

Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord I

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508205

Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508205

Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor.

30 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00586-012-2213-3

The cellular inflammatory response in human spinal cords after injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00586-012-2213-3

G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00586-012-2213-3

Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00586-012-2213-3

Does high dose methylprednisolone sodium succinate really improve neurological status in patient with acute cervical cord injury?: a prospective study about neurological recovery and early complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00586-012-2213-3

Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00586-012-2213-3

Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00586-012-2213-3

Granulocyte colony-stimulating factor (G-CSF) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00586-012-2213-3

Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00586-012-2213-3

Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00586-012-2213-3

Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00586-012-2213-3

Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00586-012-2213-3

Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction: Result of the Double-Blind, Randomized, Placebo-Controlled Stem Cells in Myocardial I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00586-012-2213-3

A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00586-012-2213-3

Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor

21 January 2018

1 reference

12 December 2020

Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures

1 reference

12 December 2020

International Standards for Neurological and Functional Classification of Spinal Cord Injury. American Spinal Injury Association

1 reference

12 December 2020

Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimul

1 reference

12 December 2020

Granulocyte colony-stimulating factor attenuates neuronal death and promotes functional recovery after spinal cord injury in mice

1 reference

12 December 2020

Feasibility and safety of granulocyte colony-stimulating factor treatment in patients with acute myocardial infarction

1 reference

12 December 2020

Neuroprotective effects of granulocyte colony-stimulating factor and relationship to promotion of angiogenesis after spinal cord injury in rats: laboratory investigation

1 reference

12 December 2020

10.1007/S00586-012-2213-3

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

22391867

1 reference